Krystal Biotech (KRYS) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 94.6%
EBITDA Margin: 50.1%
Op. Margin: 49.0%
Net Margin: 45.9%

Op. margin of 49.0% is up 8.1% YoY — cost efficiency is improving. Net margin at 45.9% and gross margin of 94.6% show how much of each revenue dollar survives to profit.

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit